Patent reform bill reported to House

Share this article:
The House Judiciary Committee voted before the summer congressional recess to approve and send to the House a bill observers said would overhaul the US patent system by weeding out bad patents and restraining excessive litigation over patents. The measure continues to be opposed by drug and biotech firms.

The bill reportedly would give parties more leeway to question patent validity and would limit damage awards in infringement cases.

“Past attempts at achieving comprehensive patent reform have met with stiff resistance,” said bill chief sponsor Rep. Howard Berman (D-CA).  

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?